Familial breast cancer (CG164)
Fast, easy summary view of NICE guidance on 'familial breast cancer'
Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer
This clinical guideline updates and replaces NICE clinical guideline 41. It offers evidence-based advice on the classification and care of people at risk of familial breast cancer. It also makes recommendations on genetic testing thresholds, surveillance and risk reduction and treatment strategies for people with a diagnosis of breast cancer and a family history of breast, ovarian or a related cancer. These areas are not covered by Early and locally advanced breast cancer (NICE clinical guideline 80).
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: familial breast cancer
This page was last updated: 29 November 2013
- Web format
- NICE Guideline (PDF)
- Full Guideline
- CG164 Canser y fron etifeddol (canser y fron yn y teulu): Gwybodaeth i'r cyhoedd (fformat MS Word)
Information for the public
Implementation tools and resources
- Baseline assessment tool
- Costing report
- Costing template
- Educational resource
- CG164 Familial breast cancer: podcast
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guideline, contains the recommendations for health professionals and NHS bodies.
The published full clinical guideline for specialists with background, evidence, recommendations and methods used.